Minsheng Royal CSI Biotechnology Thematic ETF (516930.SS) Price
Minsheng Royal CSI Biotechnology Thematic ETF Price
Minsheng Royal CSI Biotechnology Thematic ETF List of Holdings
Frequently asked questions about Minsheng Royal CSI Biotechnology Thematic ETF
Minsheng Royal CSI Biotechnology Thematic ETF is offered by Minsheng Royal, a leading player in the field of passive investments.
The ISIN of Minsheng Royal CSI Biotechnology Thematic ETF is CNE100004X99.
European investors may incur additional costs for currency exchange and transaction fees.
No, Minsheng Royal CSI Biotechnology Thematic ETF does not comply with the EU UCITS investor protection directives.
The P/E ratio of Minsheng Royal CSI Biotechnology Thematic ETF is 29.27.
Minsheng Royal CSI Biotechnology Thematic ETF tracks the performance of the CSI Biotechnology Theme Index - CNY - Benchmark TR Gross.
Minsheng Royal CSI Biotechnology Thematic ETF is domiciled in CN.
The fund was launched on 8/5/2021.
The Minsheng Royal CSI Biotechnology Thematic ETF mainly invests in Healthcare companies.
The price-to-book ratio is 2.8.
Investments can be made through brokers or financial institutions that provide access to trading ETFs.
The ETF is traded on the stock exchange, similar to stocks.
Yes, the ETF can be held in a regular securities account.
The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.
The ETF is valued on a daily stock exchange basis.
Information on dividends should be requested from the provider's website or your broker.
The risks include market fluctuations, currency risks, and the risk associated with smaller companies.
The ETF is obligated to report regularly and transparently on its investments.
The performance can be viewed on Eulerpool or directly on the provider's website.
Further information can be found on the official website of the provider.
ETF profile
Minsheng Royal CSI Biotechnology Thematic ETF